Evid Invest
Holders — by stockHoldings — by fund

First Light Asset Management, LLC

Everything this manager disclosed owning in US-listed stocks — its complete Form 13F portfolio · as of 2026-09-30 · filed with the SEC up to 45 days after quarter end · CIK 0001600004

$1.69B

disclosed book value

32

positions

9.3%

largest position share

Positions, as of 2026-09-30

top 32 of 32 · 13F covers long US-listed positions only — cash, bonds, private and foreign stakes are not disclosed · PUT/CALL tags = options positions (share-equivalents), not shares held

#IssuerSharesValue% of book
1AXGNAXOGEN INC3.7M$156.7M9.3%
2NEONEOGENOMICS INC8.5M$155.3M9.2%
3SIBNSI-BONE INC7.7M$144.5M8.6%
4AMLXAMYLYX PHARMACEUTICALS INC4.0M$116.0M6.9%
5PVLAPALVELLA THERAPEUTICS INC734,086$101.3M6%
6EWTXEDGEWISE THERAPEUTICS INC2.5M$100.8M6%
7TWSTTWIST BIOSCIENCE CORPORATION430,348$83.2M4.9%
8MASS908 DEVICES INC6.6M$82.0M4.9%
9GHGUARDANT HEALTH437,882$78.1M4.6%
10VERAVERA THERAPEUTICS INC2.0M$63.3M3.8%
11WGSGENEDX HOLDINGS CORP786,901$56.9M3.4%
12NPCENEUROPACE INC4.0M$54.8M3.2%
13TNDMTANDEM DIABETES CARE INC3.3M$53.0M3.1%
14ELVNENLIVEN THERAPEUTICS INC1.0M$46.7M2.8%
15SEPNSEPTERNA INC1.2M$45.6M2.7%
16INSPINSPIRE MEDICAL SYSTEMS INC599,653$41.6M2.5%
17SLPSIMULATIONS PLUS INC2.2M$41.3M2.4%
18ATRCATRICURE INC662,134$37.2M2.2%
19TRVITREVI THERAPEUTICS INC2.4M$34.2M2%
20TLSITRISALUS LIFE SCIENCES INC7.4M$32.0M1.9%
21IRTCIRHYTHM TECHNOLOGIES214,713$24.4M1.4%
22BFLYBUTTERFLY NETWORK INC2.6M$23.4M1.4%
23HCATHEALTH CATALYST INC12.7M$22.1M1.3%
24BBNXBETA BIONICS INC1.1M$21.1M1.2%
25ANABANAPTYS BIO INC328,523$16.5M1%
26TECXTECTONIC THERAPEUTICS INC495,950$11.6M0.7%
27BSXBOSTON SCIENTIFIC CORP237,744$10.4M0.6%
28PCVXVAXCYTE INC142,820$8.1M0.5%
29KRMDKORU MEDICAL SYSTEMS INC2.7M$8.0M0.5%
30RYTMRHYTHM PHARMACEUTICALS INC83,467$7.9M0.5%
31ESTAESTABLISHMENT LABS HOLDINGS99,219$6.4M0.4%
32BILSPDR BLOOMBERG BARCLAYS 1-3 MONTH T-BILL ETF33,181$3.0M0.2%

Source: SEC Form 13F-HR, reporting period 2026-09-30. Values are the manager's filed June-30-style quarter-end marks, not live prices. Research, not investment advice.

EvidInvest is an independent research and information tool. Figures are calculated from public SEC filings and third-party market data and are provided for informational and educational purposes only. EvidInvest does not provide investment advice, brokerage, or financial services, and is not affiliated with any company it covers. Verify all figures against primary sources before making any decision.